CA-NEXON-AMERICA
7.6.2022 15:03:34 CEST | Business Wire | Press release
MapleStory , Nexon ’s original free-to-play, side scrolling 2D MMORPG with an aggressively cute game style, announces the first of its two-part summer update, “Destiny: Remastered,” lands in-game on June 15, filled to the brim with special events, a revamp of all of Explorer jobs, plus a gift package for pre-registering before June 13!
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220607005606/en/
SPECIAL EVENTS
Summer just wouldn’t be summer in MapleStory
without some special, in-game events! It’s time for the season of music and majesty, as new friend Stella comes to experience Maple World first hand. There are a wealth of rewards to collect during the musical summer nights of Starlight Symphony
, plus the return of Tera Burning Plus
and Burning World
. On top of all that, pre-register a character (must be level 61 or above) before 11am PDT on June 13 to get a special Destiny gift package featuring Lil Symphony pets, Angelic Alphabet Damage Skin, a heap of Melody Coins to get a head start in Starlight Symphony, and a Magician of the Sacred Forest outfit!
EXPLORER REVAMP
The Explorer class of characters in MapleStory
has been the backbone of the game for the last seventeen years. These 14 unique Explorer jobs are receiving a complete overhaul of animations, improved skills, new story segments, and more.
The Explorer revamp benefits the following characters:
- Warrior : Hero, Paladin, Dark Knight
- Magician : Arch Mage (Fire/Poison), Arch Mage (Ice/Lightning), Bishop
- Bowman : Bowmaster, Marksman
- Thief : Night Lord, Shadower, Dual Blade
- Pirate : Corsair, Buccaneer, Cannoneer
IMPROVEMENTS GALORE
Incorporated into the “Destiny: Remastered” update are additional improvements, new boss accessories, and boss difficulties so everyone can enjoy a better Maple experience:
- No more Mastery Books ! - Mastery Books are no longer needed to upgrade 4th Job skills.
- Dawn Boss Accessories set - Claim a new set of accessories from bosses to forge a powerful new set.
- New Boss Difficulties - Take on Chosen Seren and Verus Hilla on normal mode and overcome Will on easy difficulty.
BEAN BRIGADE “DESTINY: REMASTERED” SNEAK PEEK
Members of MapleStory
’s content creator program, Bean Brigade
, will be jumping into the test servers early beginning today to give Maplers a sneak peek of all the exciting changes and updates coming to “Destiny: Remastered.” Follow along on Bean Brigade’s dedicated Twitch page
from June 7 through 10.
SUMMER UPDATE PART TWO
Last but not least, Summer Update Part Two, “Destiny: Homecoming,” arrives on July 20
with an all-new homestead feature allowing Maplers to purchase and decorate their very own home! Show off your exquisite taste and home decorating style, and be the envy of every other homeowner in Maple World. Also in Part Two, the Watcher Kalos awaits on top of Karote, the Unending Tower. Win in the battle against this formidable boss to obtain a new Eternal Equipment Set!
Grab your sunscreen and check out everything there is to do in MapleStory this summer!
Assets: HERE
Social Media: Twitch / Facebook / Twitter / YouTube / Website
About MapleStory
https://maplestory.nexon.net
MapleStory
is one of the largest and most active free-to-play, side-scrolling MMORPGs with over 13 million registered players from its Global services alone out of a total seven MapleStory
services around the world. First released in North America in May 2005, the game continues to grow and evolve alongside its passionate community since launching over 17 years ago. There have been over 274 million characters created to date, which would make MapleStory
’s Maple World the 4th highest populated country in the world.
About Nexon America Inc.
https://www.nexon.com/
Founded in 2005, Nexon America Inc. delivers outstanding free-to-play online game expertise and live game support, taking the strengths of NEXON Co., Ltd. (“Nexon”) and applying them for uniquely western audiences. Nexon America has consistently sustained iconic franchises such as MapleStory
and Mabinogi
for more than a decade, which have gone on to break records and captivate players. With new projects on the horizon, Nexon America maintains the pioneering and innovative spirit of its parent company, employing its player-first approach, while designing the best possible gameplay experiences for the western market.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220607005606/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom